| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1646762 | F | Growth inhibition of human NCI-H1395 cells assessed as ATP level after 96 hrs by CellTiter-Glo assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA2363470 | F | SANGER: Inhibition of human NCI-H1395 cell growth in a cell viability assay. | Homo sapiens | 137 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | ||
| 3. | ALA4256702 | F | Cytotoxicity against human NCI-H1395 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 4. | ALA4363914 | F | Additive antiproliferative activity against human NCI-H1395 cells harboring LKB1 mutant in presence of erlotinib | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA4363920 | F | Additive antiproliferative activity against human NCI-H1395 cells harboring LKB1 mutant in presence of gemcitabine | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 6. | ALA4363988 | F | Additive antiproliferative activity against human NCI-H1395 cells harboring BRAF G469A in presence of erlotinib | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA4363989 | F | Additive antiproliferative activity against human NCI-H1395 cells harboring BRAF G469A in presence of gemcitabine | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 8. | ALA4363993 | F | Antiproliferative activity against human NCI-H1395 cells | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 9. | ALA5104597 | F | Cytotoxicity against human NCI-H1395 cells assessed as cell growth inhibition incubated for 96 hrs by Cell Titer Glo assay | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!